The emerged novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARSâCoVâ2) has created a global health crisis that warrants an accurate and detailed characterization of the rapidly evolving viral genome for understanding its epidemiology, pathogenesis, and containment. Here, we explored 61,485 sequences of the nucleocapsid (N) protein, a potent diagnostic and prophylactic target, for identifying the mutations to review their roles in realâtime polymerase chain reaction based diagnosis and observe consequent impacts. Compared to the Wuhan reference strain, a total of 1034 unique nucleotide mutations were identified in the mutant strains (49.15%, nâ=â30,221) globally. Of these mutations, 367 occupy primer binding sites including the 3âČâend mismatch to the primerâpair of 11 wellâcharacterized primer sets. Noteworthily, CDC (USA) recommended the N2 primer set contained a lower mismatch than the other primer sets. Moreover, 684 amino acid (aa) substitutions were located across 317 (75.66% of total aa) unique positions including 82, 21, and 83 of those in the RNA binding Nâterminal domain (NTD), SRârich region, and Câterminal dimerization domain, respectively. Moreover, 11 inâframe deletions, mostly (nâ=â10) within the highly flexible linker region, were revealed, and the rest was within the NTD region. Furthermore, we predicted the possible consequence of highâfrequency mutations (â„20) and deletions on the tertiary structure of the N protein. Remarkably, we observed that a high frequency (67.94% of mutated sequences) coâoccuring mutations (R203K and G204R) destabilized and decreased overall structural flexibility. The N protein of SARSâCoVâ2 comprises an average of 1.2 mutations per strain compared to 4.4 and 0.4 in Middle East respiratory syndromeârelated coronavirus and SARSâCoV, respectively. Despite being proposed as the alternative target to spike protein for vaccine and therapeutics, the ongoing evolution of the N protein may challenge these endeavors, thus needing further immunoinformatics analyses. Therefore, continuous monitoring is required for tracing the ongoing evolution of the SARSâCoVâ2 N protein in prophylactic and diagnostic interventions.